These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 9501605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacologic therapy of severe heart failure].
    Kiowski W, Sütsch G, Fatio R, Schalcher C, Brunner-LaRocca HP.
    Schweiz Med Wochenschr; 1997 Dec 06; 127(49):2026-34. PubMed ID: 9476302
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS.
    J Lab Clin Med; 2001 May 06; 137(5):316-23. PubMed ID: 11329528
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based drug treatment of heart failure.
    Wasson S, Fleming D, Reddy HK.
    Mo Med; 2005 May 06; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emerging data from heart failure trials: clinical application.
    Francis G.
    Can J Cardiol; 1998 Jul 06; 14 Suppl D():27D-29D. PubMed ID: 9713428
    [No Abstract] [Full Text] [Related]

  • 9. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR.
    An R Acad Nac Med (Madr); 2006 Jul 06; 123(3):617-30. PubMed ID: 17451101
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. beta-Blocker therapy in heart failure.
    Doughty RN.
    Heart Fail Monit; 2000 Jul 06; 1(1):2-7. PubMed ID: 12634875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 06; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 15. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.
    Int J Cardiol; 2004 Feb 06; 93(2-3):105-11. PubMed ID: 14975535
    [Abstract] [Full Text] [Related]

  • 16. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD.
    Postgrad Med; 2003 Dec 06; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [Abstract] [Full Text] [Related]

  • 17. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR, Krum H.
    Curr Opin Cardiol; 2006 Jul 06; 21(4):393-9. PubMed ID: 16755210
    [Abstract] [Full Text] [Related]

  • 18. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 06; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK, Haghfelt TH.
    Ugeskr Laeger; 2006 May 08; 168(19):1854-6. PubMed ID: 16756801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.